Lumida
/ATNM
⌘K
Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc

ATNM
$1.40USD+6.87%+0.09 today

MARKET CAP

44.0M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2025TREND
Sales, Adj.$1.0M$81,000$90,000
YoY %-92.1%
P / Sales234.9x1747.3x471.4x
EV / Sales175.4x1357.1x426.3x
Gross Profit, Adj.$1.0M$81,000$90,000
YoY %-92.1%
Margin %100.0%100.0%100.0%
EV / Gross Profit175.4x1357.1x426.3x
EBITDA, Adj.$-33.4M$-51.7M$-36.1M
YoY %-30.6%-54.8%+14.0%
Margin %-3243.2%-63843.2%-40082.2%
EV / EBITDA-5.4x-2.1x-1.1x
EBIT$-34.1M$-51.9M$-36.2M
YoY %-30.6%-52.2%+13.9%
Margin %-3311.1%-64098.8%-40274.4%
EV / EBIT-5.3x-2.1x-1.1x
Net Income$-33.0M$-48.8M$-33.9M
YoY %-33.3%-47.9%+11.4%
Net Margin-3205.5%-60269.1%-37652.2%
EPS (GAAP)-$1.37-$1.83-$1.09
YoY %-14.2%-33.6%+14.2%